CTOs on the Move

Tearlab

www.tearlab.com

 
TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.tearlab.com
  • 9980 Huennekens St. Ste 100
    San Diego, CA USA 92121
  • Phone: 855.832.7522

Executives

Name Title Contact Details

Similar Companies

Nanomix

Our Vision is to make healthcare accessible to patients, without compromise, by delivering the highest quality, fastest, cost effective and portable detection systems that bring the patient and caregiver closer together.

101Mobility

101Mobility is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Arnold Dental Supply Inc

Arnold Dental Supply Inc is a Lynnwood, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Glaukos

Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.

Keating Dental Arts

Keating Dental Arts is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.